Journal List > J Korean Ophthalmol Soc > v.55(2) > 1009884

Park, Park, Yoon, and Park: Diurnal Fluctuation of Ocular Perfusion Pressure in the Fellow Eyes of Branch Retinal Vein Occlusion

Abstract

Purpose

To investigate diurnal change in blood pressure (BP), intraocular pressure (IOP), and ocular perfusion pressure (OPP) in patients with unilateral branch retinal vein occlusion (BRVO) and compare the results with healthy controls.

Methods

We conducted a prospective case‐ control study which included 50 patients with unilateral BRVO and 50 age‐ matched volunteers as controls. Each participant underwent a comprehensive ophthalmic examination including optical coherence tomography (OCT). BP and IOP were evaluated 4 times daily at 8 AM, 10 AM, 2 PM and 6 PM. The mean and fluctuation of BP, IOP, mean arterial pressure (MAP), mean OPP (MOPP), and diastolic OPP (DOPP) were compared between fellow eyes of BRVO patients and normal control eyes.

Results

The average retinal nerve fiber layer (RNFL) thickness was significantly reduced in the fellow eyes of BRVO patients compared to control eyes (p < 0.001). Mean IOP and IOP fluctuation did not differ, but BP fluctuation (systolic BP fluctuation, p = 0.045; diastolic BP fluctuation, p = 0.037) and MAP fluctuation (p = 0.011) were greater in the fellow eyes of BRVO patients compared to normal eyes. The mean MOPP and DOPP did not differ between groups, however, the fluctuation of MOPP (p < 0.001) and DOPP (p < 0.001) were significantly increased in the fellow eyes of BRVO patients. The mean and fluctuation of BP, MAP, MOPP and DOPP were associated with reduced average RNFL thickness in the fellow eyes of BRVO patients.

Conclusions

These results suggest the fellow eyes of unilateral BRVO patients may be at risk of developing glaucomatous damage.

References

1. David R, Zangwill L, Badarna M, Yassur Y.Epidemiology of reti-nal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica. 1988; 197:69–74.
crossref
2. Glacet-Bernard A, Coscas G, Chabanel A. . Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology. 1996; 103:551–60.
3. Klein BE, Meuer SM, Knudtson MD, Klein R.The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study. Am J Ophthalmol. 2006; 141:859–62.
crossref
4. McGrath MA, Wechsler F, Hunyor AB, Penny R.Systemic factors contributory to retinal vein occlusion. Arch Intern Med. 1978; 138:216–20.
crossref
5. Peduzzi M, Debbia A, Guerrieri F, Bolzani R.Abnormal blood rheology in retinal vein occlusion. A preliminary report. Graefes Arch Clin Exp Ophthalmol. 1986; 224:83–5.
6. Rath EZ, Frank RN, Shin DH, Kim C.Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992; 99:509–14.
7. Barnett EM, Fantin A, Wilson BS. et al. Ocular Hypertension Treatment Study Group. The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology. 2010; 117:484–8.
8. Cugati S, Wang JJ, Rochtchina E, Mitchell P.Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol. 2006; 124:726–32.
9. Klein R, Klein BE, Moss SE, Meuer SM.The epidemiology of reti-nal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000; 98:133–41.
10. Mitchell P, Smith W, Chang A.Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996; 114:1243–7.
11. Hayreh SS, Zimmerman MB, Beri M, Podhajsky P.Intraocular pressure abnormalities associated with central and hemicentral ret-inal vein occlusion. Ophthalmology. 2004; 111:133–41.
crossref
12. The Eye Disease Case-Control Study Group. Risk factors for cen-tral retinal vein occlusion. Arch Ophthalmol. 1996; 114:545–54.
13. Sperduto RD, Hiller R, Chew E. . Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1998; 105:765–71.
14. Hafez AS, Bizzarro RL, Rivard M, Lesk MR.Changes in optic nerve head blood flow after therapeutic intraocular pressure reduc-tion in glaucoma patients and ocular hypertensives. Ophthalmology. 2003; 110:201–10.
crossref
15. Tielsch JM, Katz J, Sommer A. . Hypertension, perfusion pres-sure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995; 113:216–21.
16. Sehi M, Flanagan JG, Zeng L. . Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:561–7.
crossref
17. Choi J, Jeong J, Cho HS, Kook MS.Effect of nocturnal blood pres-sure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci. 2006; 47:831–6.
crossref
18. Ozbek Z, Saatci AO, Durak I. . Colour Doppler assessment of blood flow in eyes with central retinal vein occlusion. Ophthal- mologica. 2002; 216:231–4.
crossref
19. Tranquart F, Arsene S, Giraudeau B. . Initial color Doppler findings in retinal vein occlusion. J Clin Ultrasound. 2000; 28:28–33.
crossref
20. Leske MC, Wu SY, Nemesure B, Hennis A.Incident open-angle glaucoma and blood pressure. Arch Ophthalmol. 2002; 120:954–9.
crossref
21. Sehi M, Flanagan JG, Zeng L. . Anterior optic nerve capillary blood flow response to diurnal variation of mean ocular perfusion pressure in early untreated primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:4581–7.
crossref
22. The Eye Disease Case-control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol. 1993; 116:286–96.
23. Arséne S, Giraudeau B, Le Lez ML. . Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol. 2002; 86:1243–7.
24. Williamson TH, Lowe GD, Baxter GM.Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities. Br J Ophthalmol. 1995; 79:17–22.
crossref
25. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D.Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982; 100:1132–40.
crossref
26. Paton A, Rubinstein K, Smith VH.Arterial insufficiency in retinal venous occlusion (a short symposium). Trans Ophthalmol Soc U K. 1964; 84:559–95.
27. Rabinowicz IM, Litman S, Michaelson IC.Branch venous throm-bosis–a pathological report. Trans Ophthalmol Soc U K. 1969; 88:191–210.
28. Stewart RM, Clearkin LG.Insulin resistance and autoregulatory dysfunction in glaucoma and retinal vein occlusion. Am J Ophthalmol. 2008; 145:394–6.
crossref
29. Kim MJ, Woo SJ, Park KH, Kim TW.Retinal nerve fiber layer thickness is decreased in the fellow eyes of patients with unilateral retinal vein occlusion. Ophthalmology. 2011; 118:706–10.
crossref

Figure 1.
Comparison of optical coherence tomography clock- hour retinal nerve fiber layer (RNFL) thickness profiles between healthy eyes, branched retinal vein occlusion eyes, and unaffected fellow eyes.
jkos-55-237f1.tif
Figure 2.
Fluctuation of intraocular pressure (IOP) and ocular perfusion pressure (OPP) in healthy control eyes and fellow eyes of unilateral branched retinal vein occlusion. The mean diurnal variation of IOP, mean OPP (MOPP) and mean diastolic OPP (DOPP) at different time points are shown (left column). The mean IOP, MOPP, and DOPP shows no significant difference at any time point between groups. The absolute diurnal changes of MOPP and DOPP shows significant difference (*) between the control eyes versus fellow eyes (right column).
jkos-55-237f2.tif
Figure 3.
Representative case 1: 52-year-old man with branched retinal vein occlusion (BRVO) in the left eye. Larger diurnal MOPP, and DOPP fluctuation are observed in the fellow eye of the patient, compared to the mean of control eyes. The localized retinal nerve fiber layer (RNFL) defect is found in the superotemporal area in the fellow eye and superotemporal RNFL is reduced on OCT measurements.
jkos-55-237f3.tif
Table 1.
Mean retinal nerve fiber layer thickness measured by optical coherence tomography
  Control Fellow eyes BRVO eyes p-value* p-value p-value
Average 110.52 ± 10.45 92.78 ± 13.35 69.79 ± 13.10 <0.001 <0.001 <0.001
Quadrant            
  Temporal 76.05 ± 10.79 70.73 ± 8.81 62.25 ± 8.93 0.033 0.004 0.665
  Superior 125.52 ± 11.84 111.06 ± 20.68 89.32 ± 18.47 0.011 <0.001 <0.001
  Nasal 75.06 ± 7.77 74.49 ± 11.24 64.87 ± 8.74 0.257 0.024 0.152
  Inferior 127.47 ± 11.41 111.83 ± 12.67 103.72 ± 16.26 <0.001 <0.001 0.193
Clock hours            
  1 125.77 ± 17.39 119.50 ± 26.37 99.31 ± 28.07 0.013 <0.001 <0.001
  2 87.45 ± 19.30 81.30 ± 15.85 74.18 ± 16.83 0.378 0.214 0.360
  3 63.45 ± 7.81 60.20 ± 7.34 55.48 ± 10.11 0.455 0.489 0.532
  4 70.99 ± 14.19 68.09 ± 9.13 57.67 ± 7.29 0.314 0.303 0.157
  5 139.67 ± 21.75 120.45 ± 21.81 94.35 ± 20.11 <0.001 <0.001 <0.001
  6 140.13 ± 22.57 131.74 ± 27.89 118.32 ± 27.42 0.040 <0.001 0.017
  7 112.03 ± 17.44 95.56 ± 15.31 86.89 ± 14.73 <0.001 <0.001 0.164
  8 77.06 ± 11.06 73.60 ± 12.90 62.12 ± 8.48 0.212 0.004 0.054
  9 70.83 ± 10.04 62.35 ± 9.92 59.48 ± 10.02 0.236 0.017 0.608
  10 84.31 ± 14.13 80.55 ± 17.90 73.49 ± 14.61 0.172 0.048 0.366
  11 110.59 ± 19.00 102.61 ± 30.09 84.34 ± 19.88 0.147 <0.001 <0.001
  12 130.66 ± 20.05 118.43 ± 27.04 84.78 ± 23.11 <0.001 <0.001 <0.001

Values are presented as mean ± SD.

BRVO = branch retinal vein occlusion.

* Comparison between control and fellow eyes

Comparison between control and BRVO eyes

Comparison between fellow and BRVO eyes.

Table 2.
Systemic and ocular measurements
  Normal controls BRVO patients p-value
Number 50 50  
Age (years) 63.63 ± 6.54 64.84 ± 5.67 0.721
Sex (male:female) 28:22 26:24 0.665
Spherical equivalent (diopters)* -0.63 ± 1.11 -0.54 ± 1.27 0.713
Intraocular pressure (mm Hg)*      
  Mean 14.35 ± 2.33 14.54 ± 2.35 0.990
  Peak 15.50 ± 2.39 16.27 ± 2.16 0.146
  Fluctuation 1.59 ± 0.85 2.07 ± 0.96 0.112
Visual field exam (dB)*      
  Mean deviation -0.64 ± 2.46 -1.47 ± 1.26 0.255
  Pattern standard deviation 1.57 ± 2.14 1.94 ± 1.04 0.131
Systemic hypertension (n) 10 (20.0%) 30 (60.0%) <0.001
  Taking antihypertensive medication 8 (80.0%) 25 (83.3%) 0.831
Systolic BP (mm Hg)      
  Mean 125.93 ± 12.66 136.48 ± 12.19 0.164
  Fluctuation 18.8 ± 3.55 25.67 ± 3.53 0.045
Diastolic BP (mm Hg)      
  Mean 73.43 ± 11.94 80.60 ± 22.68 0.201
  Fluctuation 19.0 ± 5.04 27.23 ± 4.86 0.037
Mean arterial pressure (mm Hg)      
  Mean 92.26 ± 9.82 92.56 ± 10.35 0.535
  Fluctuation 10.22 ± 7.03 19.89 ± 9.85 0.011

Values are presented as mean ± SD.

BRVO = branch retinal vein occlusion; BP = blood pressure.

* Values are for the unaffected fellow eyes in the RVO patients

By independent t-test

By chi-square test.

Table 3.
Measurements in intraocular pressure and ocular perfusion pressure
  Control eyes Fellow eyes p-value*
Ocular perfusion pressure      
  Mean 47.16 ± 2.72 47.05 ± 2.08 0.791
  Fluctuation 10.27 ± 2.31 17.71 ± 3.32 <0.001
Diastolic ocular perfusion pressure      
  Mean 36.60 ± 2.85 35.45 ± 2.15 0.573
  Fluctuation 10.01 ± 3.18 18.13 ± 3.36 <0.001

Values are presented as mean ± SD.

* By independent t-test.

Table 4.
Significance of independent variables in predicting outcomes of retinal nerve fiber layer thickness in the fellow eyes of unilateral BRVO by univariate models
Variable Beta [95% CI] p-value
Age 1.012 [0.721-4.433] 0.601
SE 0.934 [0.315-1.216] 0.522
History of systemic hypertension 1.167 [0.916-5.973] 0.048*
Systemic antihypertensive medication 1.033 [0.840-5.723] 0.379
VF MD 1.046 [0.753-3.816] 0.462
VF PSD 1.058 [0.801-3.573] 0.411
Mean IOP 1.121 [1.014-4.168] 0.130
Peak IOP 1.008 [0.912-3.410] 0.286
IOP fluctuation 1.104 [0.830-3.533] 0.187
Mean SBP 0.572 [0.313-0.914] 0.518
SBP fluctuation 1.032 [0.852-4.260] 0.386
Mean DBP 1.040 [0.971-1.114] 0.247
DBP fluctuation 1.173 [1.015-2.016] 0.016*
Mean MAP 0.928 [0.716-1.097] 0.540
MAP fluctuation 1.043 [0.917-1.180] 0.382
MOPP 1.044 [0.985-1.116] 0.251
MOPP fluctuation 1.028 [0.999-2.005] 0.256
Mean DOPP 1.128 [1.087-2.025] 0.200
DOPP fluctuation 0.163 [1.121-2.309] 0.009*

BRVO = branched retinal vein occlusion; SE = spherical equivalent; VF = visual field; MD = mean deviation; PSD = pattern standard deviation; IOP = intraocular pressure; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; MOPP = mean ocular perfusion pressure; DOPP = diastolic ocular perfusion pressure.

* p < 0.05.

Table 5.
Significance of independent variables in predicting outcomes of retinal nerve fiber layer thickness in the fellow eyes of unilateral BRVO by multivariate models
Variable Beta [95% CI] p-value
Age 1.008 [0.578-3.267] 0.720
SE 0.819 [0.310-1.082] 0.618
History of systemic hypertension 1.964 [0.893-4.510] 0.097
Systemic antihypertensive medication 0.617 [0.127-1.815] 0.446
DOPP fluctuation 1.911 [1.184-4.630] 0.005*

BRVO = branch retinal vein occlusion; SE = spherical equivalent; DOPP = diastolic ocular perfusion pressure.

* p < 0.05.

TOOLS
Similar articles